Peer Review reports
From: Clinical rebound after treatment with nirmatrelvir/ritonavir in COVID-19
| Original Submission | ||
|---|---|---|
| 29 May 2024 | Submitted | Original manuscript |
| 24 Jul 2024 | Reviewed | Reviewer Report |
| 5 Aug 2024 | Reviewed | Reviewer Report |
| 21 Aug 2024 | Author responded | Author comments - Chad J. Achenbach |
| Resubmission - Version 2 | ||
| 21 Aug 2024 | Submitted | Manuscript version 2 |
| 21 Aug 2024 | Author responded | Author comments - Chad J. Achenbach |
| Resubmission - Version 3 | ||
| 21 Aug 2024 | Submitted | Manuscript version 3 |
| 30 Aug 2024 | Author responded | Author comments - Chad J. Achenbach |
| Resubmission - Version 4 | ||
| 30 Aug 2024 | Submitted | Manuscript version 4 |
| Publishing | ||
| 30 Aug 2024 | Editorially accepted | |
| 12 Sep 2024 | Article published | 10.1186/s12879-024-09842-8 |
You can find further information about peer review here.